ARK THERAPEUTICS GROUP PLC | 0,002 Euro | -0,001 -33,33 % | |
| WKN: A0B9EW ISIN: GB0034251727 Ticker-Symbol: TXF | Frankfurt | 24.05.13 | 08:10 Uhr |
Branche BiotechnologieAktienmarkt FTSE techMARK Focus |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 24.05. | Ark Therapeutics Grp: Second Price Monitoring Extn | - | InvestEgate | |
| 24.05. | Ark Therapeutics Grp: Price Monitoring Extension | - | InvestEgate | |
| 17.05. | Ark Therapeutics Grp: Interim Management Statement | - | InvestEgate | |
| 16.05. | Ark Therapeutics Grp: Holding(s) in Company | 1 | InvestEgate | |
| 08.05. | Ark Therapeutics Grp: Holding(s) in Company | - | InvestEgate | |
| 02.05. | Ark Therapeutics Grp: Holding(s) in Company | - | InvestEgate | |
| 01.05. | Ark Therapeutics Grp: Price Monitoring Extension | 2 | InvestEgate | |
| 30.04. | Ark Therapeutics pre-tax losses rise | - | StockMarketWire | |
| 30.04. | Ark Therapeutics Grp: Final Results | - | InvestEgate | |
| 24.04. | Ark Therapeutics Grp: Holding(s) in Company | - | InvestEgate | |
| 26.03. | Ark Therapeutics Grp: Second Price Monitoring Extn | - | InvestEgate | |
| 26.03. | Ark Therapeutics Grp: Price Monitoring Extension | 1 | InvestEgate | |
| 19.03. | Ark Therapeutics Grp: Holding(s) in Company | - | InvestEgate | |
| 15.03. | UPDATE 1-Ark Therapeutics sells two units; shares plunge | 1 | Reuters.com | |
| 15.03. | Ark Therapeutics sells two units; shares plunge | - | Reuters.com | |
| 15.03. | Ark Therapeutics Grp: Termination of Offer Period and Rule 10.8 Waiver | - | InvestEgate | |
| 25.02. | Ark Therapeutics Grp: Holding(s) in Company | - | InvestEgate | |
| 20.02. | ABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics plc | 45 | PR Newswire | |
| FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A
PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a)... Mehr lesen zu: ABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics plc | ||||
| 19.02. | Ark Therapeutics Grp: Second Price Monitoring Extn | - | InvestEgate | |
| 19.02. | Ark Therapeutics Grp: Price Monitoring Extension | 1 | InvestEgate | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| NOVEMBER | 0,031 | +3,33 % | EANS-PVR: november Aktiengesellschaft / Veröffentlichung gemäß § 26 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung |
| PAION | 0,689 | -1,43 % | Paion: 10 Prozent Aufschlag |
| EMISPHERE TECHNOLOGIES | 0,093 | +20,78 % | XFRA FRA:Deletion of Instruments from XETRA - 14.12.2012-015 |
| EVOTEC | 2,75 | -0,58 % | Evotec-Aktie: Jetzt einsteigen! |
| SYGNIS PHARMA | 2,60 | -0,76 % | Qiagen und SYGNIS Pharma schließen Lizenzvertrag |
